Literature DB >> 21112523

Ameloblastic carcinoma, secondary type: a case report.

Kazunari Karakida1, Takayuki Aoki, Haruo Sakamoto, Miho Takahashi, Tadashi Akamatsu, Go Ogura, Yasutomo Sekido, Yoshihide Ota.   

Abstract

Malignant variants of ameloblastoma include metastasizing ameloblastoma, which microscopically appears benign but has metastasized and ameloblastic carcinoma that exhibits malignant histopathologic features. Ameloblastic carcinoma is classified into 2 types: a primary odontogenic malignancy and a secondary type resulting from malignant transformation of ameloblastoma. Most secondary ameloblastic carcinomas result from malignant transformation of a primary lesion after repeated postsurgical recurrences. Therefore it is rare to find an untreated secondary type presenting with histologic features of malignant transformation from an earlier benign lesion. We experienced a rare case of ameloblastic carcinoma, secondary type which might arise in an untreated ameloblastoma. The mechanism by which a preexisting benign ameloblastoma goes through a malignant transformation is also described. Crown
Copyright © 2010. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21112523     DOI: 10.1016/j.tripleo.2010.08.018

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  13 in total

1.  Ameloblastic Carcinoma: A Rare Malignant Tumour in Maxillofacial Region.

Authors:  Pushkar Devidas Gawande; Kiran Khande; Gaurav Agrawal; Amita Aditya
Journal:  J Maxillofac Oral Surg       Date:  2016-10-03

2.  Ameloblastic carcinoma of the maxilla: A case report.

Authors:  Diurianne Caroline Campos França; João Milanez Moreira; Sandra Maria Herondina Coelho Ávila DE Aguiar; Artur Aburad DE Carvalhos; Marcelo Coelho Goiato
Journal:  Oncol Lett       Date:  2012-09-25       Impact factor: 2.967

3.  Ameloblastic Carcinoma.

Authors:  Dakshika Abeydeera Gunaratne; Hedley G Coleman; Lydia Lim; Gary J Morgan
Journal:  Am J Case Rep       Date:  2015-07-01

4.  Ameloblastic carcinoma: A clinicopathologic dilemma - Report of two cases with total review of literature from 1984 to 2012.

Authors:  Indu Bhusan Kar; R V Subramanyam; Niranjan Mishra; Akhilesh Kumar Singh
Journal:  Ann Maxillofac Surg       Date:  2014-01

5.  Primary intraosseous squamous cell carcinoma of the maxilla possibly arising from an infected residual cyst: A case report.

Authors:  Shintaro Sukegawa; Hidenobu Matsuzaki; Naoki Katase; Takahiro Kanno; Toshiko Mandai; Yuka Takahashi; Jun-Ichi Asaumi; Yoshihiko Furuki
Journal:  Oncol Lett       Date:  2014-10-27       Impact factor: 2.967

Review 6.  Ameloblastic carcinoma of the mandible: Report of a case and review.

Authors:  Shreenivas Kallianpur; Sanjay Jadwani; Biswajit Misra; U S Sudheendra
Journal:  J Oral Maxillofac Pathol       Date:  2014-09

7.  Multi-recurrent invasive ameloblastoma: A surgical challenge.

Authors:  Fatemah Faras; Fawaz Abo-Alhassan; Yona Israël; Barbara Hersant; Jean-Paul Meningaud
Journal:  Int J Surg Case Rep       Date:  2016-11-21

8.  Comparative histological and immunohistochemical study of ameloblastomas and ameloblastic carcinomas.

Authors:  M Martínez-Martínez; A Mosqueda-Taylor; R Carlos-Bregni; F-R Pires; W Delgado-Azanero; R Neves-Silva; B Aldape-Barrios; O Paes-de Almeida
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2017-05-01

9.  Ameloblastic carcinoma: An analysis of 12 cases with a review of the literature.

Authors:  Jia Li; Hongming DU; Peng Li; Jingkui Zhang; Weidong Tian; Wei Tang
Journal:  Oncol Lett       Date:  2014-06-05       Impact factor: 2.967

10.  Usefulness of 11C-methionine positron emission tomography for detecting intracranial ameloblastic carcinoma: A case report.

Authors:  Akira Tempaku; Yoshinobu Takahashi; Hidetoshi Ikeda; Shigeru Yamauchi; Takashi Gotoh; Nobuyuki Bandoh; Syujirou Makino; Takuji Shimada; Hajime Kamada
Journal:  Oncol Lett       Date:  2014-07-15       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.